Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

Clinical trial NCT06353087 · COMPLETED

Trial details

NCT number: NCT06353087
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Dermatitis, Atopic Dermatitis Eczema Skin Diseases Immune System Diseases Janus Kinase Inhibitors

Start date: 2024-06-19
Primary completion: 2026-06-22
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.